Physician

Afreen Idris Shariff, M.D.

According to 2025 Medicare claims, Afreen Shariff, M.D. (NPI: 1699061796) practices endocrinology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27713-8505. Shariff is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), participating under the MSSP model.

Shariff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 170 traditional Medicare patients, billed 452 HCPCS/CPT codes, and received $29,862 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,779 prescription claims across 275 beneficiaries totaling $550,729 in drug costs, led by Jardiance (Empagliflozin). DME data shows 91 claims. Open Payments data shows 23 records totaling $21,860. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $15,874 to $29,862. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,995 to $550,729. For DME billing, reported payments moved sharply higher in recent years, from $1,279 to $29,763.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	111	114	$15,874
2016	N/R	N/R	N/R
2017	53	66	$3,507
2018	119	261	$16,124
2019	140	371	$26,239
2020	184	430	$32,799
2021	221	528	$39,023
2022	207	425	$28,531
2023	184	374	$29,810
2024	170	452	$29,862

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	67	$3,995
2016	32	148	$38,564
2017	56	277	$83,389
2018	65	307	$102,110
2019	95	653	$208,214
2020	155	1,063	$251,834
2021	200	1,421	$471,641
2022	234	1,626	$613,724
2023	230	1,401	$568,824
2024	275	1,779	$550,729

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	15	$508
2018	N/R	N/R	N/R
2019	N/R	41	$5,027
2020	N/R	77	$11,929
2021	11	91	$12,967
2022	12	169	$26,755
2023	11	88	$17,098
2024	15	91	$27,542

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	18	18	$164
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	107	148	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	52	55	$65
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	18	24	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	121	157	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	139	8,058	$155,355
Ozempic	Semaglutide	72	2,904	$90,484
Trulicity	Dulaglutide	26	1,468	$49,352
Mounjaro	Tirzepatide	32	1,204	$44,609
Rybelsus	Semaglutide	16	780	$23,420

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	15	56	$22,293
E0784	External ambulatory infusion pump, insulin	Y	N/R	13	$4,150
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	11	$756
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	11	$343

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$21,860	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Afreen Idris Shariff, M.D.?

Tedicare shows public-source Medicare data for Afreen Idris Shariff, M.D. (NPI 1699061796), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afreen Idris Shariff, M.D. have ACO affiliation data?

Afreen Idris Shariff, M.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419).

What billing organization is linked to Afreen Idris Shariff, M.D.?

Afreen Idris Shariff, M.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Afreen Idris Shariff, M.D. have Open Payments data?

Afreen Idris Shariff, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.